Dna X (SONM) Research & Development (2018 - 2025)

Dna X has reported Research & Development for 8 years, with the latest figure at $181000.0 in Q3 2025.

• For the quarter ending Q3 2025, Research & Development fell 74.69% year-over-year to $181000.0; the trailing twelve-month figure through Sep 2025 stood at $15.2 million (up 473.85% YoY), and the FY2024 full-year result was $14.2 million, up 703.33% from the prior year.
• Research & Development for Q3 2025 stood at $181000.0, down from $909000.0 in the prior quarter.
• The five-year high for Research & Development was $12.5 million in Q4 2024, with the low at -$135000.0 in Q3 2022.
• Historically, Research & Development has averaged $2.5 million across 5 years, with a median of $1.1 million in 2022.
• Annual changes were most pronounced in 2022 — Research & Development sank 102.46% — and 2024, when it surged 1250.65%.
• Dna X's Research & Development stood at $3.9 million in 2021, then sank by 68.5% to $1.2 million in 2022, then retreated by 24.04% to $926000.0 in 2023, then surged by 1250.65% to $12.5 million in 2024, then slumped by 98.55% to $181000.0 in 2025.
• The last three Research & Development figures came in at $181000.0 (Q3 2025), $909000.0 (Q2 2025), and $1.6 million (Q1 2025), per Business Quant data.